Potential Role of Tranexamic Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation
JAMA Dermatology · 2024
DOI: 10.1001/jamadermatol.2023.5470 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA Dermatology, 2024. Verfasst von David A Hashemi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laser & Skin Surgery Center of New York, New York. Hauptthemen laut MEDLINE: Tranexamic Acid, Laser Therapy, Low-Level Light Therapy, Hyperpigmentation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laser & Skin Surgery Center of New York, New York.
- Laser & Skin Surgery Center of Pennsylvania, Devon.
- The Ronald O. Perelman Department of Dermatology, New York University Langone Health, New York.
Zitieren
APA
Hashemi, D. A., Wang, J. V., & Geronemus, R. G. (2024). Potential Role of Tranexamic Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2023.5470
Vancouver
Hashemi DA, Wang JV, Geronemus RG. Potential Role of Tranexamic Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation. JAMA Dermatology. 2024. doi:10.1001/jamadermatol.2023.5470
BibTeX
@article{Hashemi2024,
author = {Hashemi, David A and Wang, Jordan V and Geronemus, Roy G},
title = {Potential Role of Tranexamic Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation},
journal = {JAMA Dermatology},
year = {2024},
doi = {10.1001/jamadermatol.2023.5470}
}
EUVIMED